Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma: A Southwest Oncology Group Study

Cancer Genetics and Cytogenetics

Volumn 99, Issue 1, 1997, Pages 45-53

  Mohamed, Anwar N ^a   Zalupski, Mark M ^a   Ryan, James R ^b   Koppitch, Fred ^a   Balcerzak, Stanley ^c   Kempf, Raymond ^d   Wolman, Sandra R ^e  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CHROMOSOME 1; CHROMOSOME 12; CHROMOSOME 14; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CLINICAL ARTICLE; CYTOGENETICS; DIPLOIDY; DNA CONTENT; FEMALE; HUMAN; HUMAN TISSUE; KARYOTYPE; MALE; NUMERICAL CHROMOSOME ABERRATION; PLOIDY; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; TETRAPLOIDY;

ADOLESCENT; ADULT; AGED; ANEUPLOIDY; CHILD; CHROMOSOME ABERRATIONS; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0030773716     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00434-7     Document Type: Article

References (38)

1. Donner LR (1994): Cytogenetics of tumors of soft tissue and bone. Implication of Pathology. Cancer Genet Cytogenet 78:115-126.
2. Sandberg AA, Bridge JA (1994): The Cytogenetics of Bone and Soft Tissue Tumors. RG Landes Company, Austin.
3. Sreekantaiah C, Ladanyi M, Rodriguez E, Chaganti RSK (1994): Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification and molecular mechanisms. Am J Path 144:1121-1134.
4. Limon J, Mrozek K, MandahlMN N, Nedoszytko B, Verhest A, Rys J, Niezabitowski A, Babinska M, Nosek H, Ochalek T, Kopacz A, Willén H, Rydholm A, Heim S, Mitelman F (1991): Cytogenetics of synovial sarcoma: Presentation of ten new cases and review of the literature. Genes Chromosom Cancer 3:338-345.
5. Turc-Carel C, Limon J, Dal Cin P, Rao U, Karakousis C, Sandberg AA (1986): Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(ql3;pll) in myxoid liposarcomas. Cancer Genet Cytogenet 23:291-299.
6. Turc-Carel C, Aurias A, Mugneret F, Lizard S, Sidaner I, Volk C, Thiery JP, Olschwang S, Philip I, Berger MP, Philip T, Lenoir GM, Mazabraud A (1988): Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases and remarkable consistency of t(ll;22)(q24;ql2). Cancer Genet Cytogenet 32:229238.
7. Donner LR (1991): Cytogenetics and molecular biology of small round-cell tumors and related neoplasms. Current status. Cancer Genet Cytogenet 54:1-10.
8. Whang-Peng J, Knutsen T, Theil K, Harowitz ME, Triche T (1992): Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosom Cancer 5:299-310.
9. Peulve P, Michot C, Vannier JP, Tron P, Hemet J (1991): Clear cell sarcoma with t(12;22)(ql3-14;ql2). Genes Chromosom Cancer 3:400-402.
10. Zuchman J, Delattre O, Desmaze C, Plougastel B, Joubert I, Melot T, Peter M, De Jong P, Rouleau G, Aurias A, Thomas G (1992): Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosom Cancer 5:271-277.
11. Barr FG, Galili N, Holick J, Biegel JA, Rovera G, Emanuel BS (1993): Rearrangement of the PAX3 paired box gene in the pediatric solid tumour alveolar rhabdomyosarcoma. Nature Genet 3:113-117.
12. Rabbitts TH, Forster A, Larson R, Nathan P (1993): Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nature Genet 4:175-180.
13. Wolman RS, Camuto PM, Golimbu M, Schinella R (1988): Cytogenetics, flow cytometric, ultrastructural studies of twentynine nonfamilial human renal carcinomas. Cancer Res 48: 2890-2897.
14. Zalupski M, Ryan J, Ensley J, Maciorowski Z, Pietraszkiewicz H, Hussein M, Kukuruga M, Sundareson A, Baker L (1993): Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasms. Cytometry 4:922-930.
15. Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Gohde W, Andreeff M, Freireich E (1983): Flow cytometry in clinical cancer Research. Cancer Res 43:3977-3982.
16. Baisch H, Golde W, Linden WA (1975): Analysis of PCP data to determine the fraction of cells in various phases of the cell cycle. Radiat Environ Biophys 12:31-39.
17. Mohamad AN, Wolman SR (1995): Chromosome analysis in cell culture. In: Cell Growth and Apoptosis; A Practical Approach 2nd ed. George Studzinski, ed. Oxford University Press, 2:79-96.
18. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
19. Shackney SE, Burholt DR, Pollice AA, Smith CA, Pugh RP, Hartsock RJ (1990): Discrepancies between flow cytometric and cytogenetic studies in the detection of aneuploidy in human solid tumors. Cytometry 11:94-104.
20. Lakkala T, Laasonen A, Franssila KO, Terrenhovi L, Knutila S (1990): Comparison of DNA and karyotype aneuploidy in malignant lymphomas. Am J Clin Path 94:600-605.
21. Gaynor JJ, Tan CC, Casper ES, Collin CF, Friedrich C, Shiu M, Hadju SI, Brennan MF (1992): Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: A study of 423 adults. J Clin Oncol 10:1317-1329.
22. Becher R, Wake N, Gibas Z, Ochi H, Sandberg AA (1984): Chromosome changes in soft tissue sarcomas. JNC1 72:823-831.
23. Mandahl N, Heim S, Arheden K, Rhydholm A, Willén H, Mitelman F (1988): Rings, dicentrics, and telomeric association in histiocytomas. Cancer Genet Cytogenet 30:23-33.
24. Fletcher JA, Kozakewich HP, Hoffer FA, Lage JM, Weidner N, Tepper R, Pinkus GS, Morton CC, Corson JM (1991): Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med 324:436-443.
25. Weiss SW (1982): Malignant fibrous histiocytoma. A reaffirmation. Am J Surg Path 6:773-784.
26. Jabi M, Jeans D (1987): Ultrastructural heterogeneity in malignant fibrous histiocytoma of the soft tissue. Ultrastruct Pathol 11:583-592.
27. Orndal C, Rydholm A, Willén H, Mitelman F (1994): Cytogenetic intratumor heterogeneity in soft tissue tumors. Cancer Genet Cytogenet 78:127-137.
28. Bigner SH, Mark J, Burger PC, Mahaley MS Jr, Bullard DE, Muhlbaier LH, Bigner DD (1988): Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48:405-411.
29. Stadler WM, Sherman J, Bohlander SK, Roulston D, Dreyling M, Rukstalis D, Olopde OI (1994): Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res 54:2060-2063.
30. Olopade OI, Buchhagen DL, Malik K, Sherman J, Nobori T, Bader S, Nau MM, Gazdar AF, Minna JD, Diaz MO (1993): Homozygous loss of the Interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 53:2410-2415.
31. Center R, Lukeis R, Dietzsch E, Gillespie M, Garson OM (1993): Molecular deletion of 9p sequences in non-small cell lung cancer and malignant mesothelioma. Genes Chromosom Cancer 7:47-53.
32. Fountain JW, Karayiorgou M, Ernstoff MS, Kirkwood JM, Vlock DR, Titus-Ernstoff L, Bouchard B, Vijayasaradhi S, Houghton AN, Lahti J, Kidd VJ, Housman DE, Dracopoli NC (1992): Homozygous deletions within human chromosome band dand9p21 in melanoma. Proc Natl Acad Sci USA 89:10557-10561.
33. James C, HE J, Carlbom E, Nordenskjold M, Cavenee WK, Collons VP (1991): Chromosome 9 deletion mapping reveals Interferon and interferon-1 gene deletions in human glial tumors. Cancer Res 51:1684-1688.
34. Moch H, Presti JC, Guido S, Buchholz N, Jordan P, Mihatsch MJ, Woldman FM (1996): Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 56:27-30.
35. Vandeløv LL, Christensen IJ, Jensen G, Nissen NI (1983): Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods of sample-storage, staining and international standardization. Cytometry 3:332-339.
36. Manhahl N, Baldetorp B, Ferno M, Akerman M, Rydholm A, Heim S, Willen H, Killander D, Mitelman F (1993): Comparative cytogenetic and DNA flow cytometric analysis of 150 bone and soft-tissue tumors. Int J Cancer 53:358-364.
37. Grierson HL, Wooldridge TN, Hess M, Wooldridge L, Ratashak A, Bast M, Armitage JO, Weisenburger DD, Sanger WG (1995): Comparison of DNA content in nonHodgkin's lymphoma as measured by flow cytometry and cytogenetics. Cancer Genet Cytogenet 80:124-128.
38. Zalupski M, Pietraszkiewicz H, Ryan J, Reed M, Ensley J (1992): DNA ploidy changes during short term culture of soft tissue and bone tumors. Proc. AACR, #586.